Targeting of activated fibroblasts for imaging and therapy
Tumors form a complex environment consisting of a variety of non-malignant cells. Especially cancer-associated fibroblasts have been shown to have an important role for different aspects of malignant tumors such as migration, metastasis, resistance to chemotherapy and immunosuppression. Therefore, a...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 July 2019
|
| In: |
EJNMMI radiopharmacy and chemistry
Year: 2019, Jahrgang: 4, Pages: 1-15 |
| ISSN: | 2365-421X |
| DOI: | 10.1186/s41181-019-0069-0 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s41181-019-0069-0
|
| Verfasserangaben: | Thomas Lindner, Anastasia Loktev, Frederik Giesel, Clemens Kratochwil, Annette Altmann and Uwe Haberkorn |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1742221351 | ||
| 003 | DE-627 | ||
| 005 | 20240612084643.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201207s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s41181-019-0069-0 |2 doi | |
| 035 | |a (DE-627)1742221351 | ||
| 035 | |a (DE-599)KXP1742221351 | ||
| 035 | |a (OCoLC)1341383115 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lindner, Thomas |e VerfasserIn |0 (DE-588)107520318X |0 (DE-627)833005804 |0 (DE-576)443314772 |4 aut | |
| 245 | 1 | 0 | |a Targeting of activated fibroblasts for imaging and therapy |c Thomas Lindner, Anastasia Loktev, Frederik Giesel, Clemens Kratochwil, Annette Altmann and Uwe Haberkorn |
| 264 | 1 | |c 25 July 2019 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.12.2020 | ||
| 520 | |a Tumors form a complex environment consisting of a variety of non-malignant cells. Especially cancer-associated fibroblasts have been shown to have an important role for different aspects of malignant tumors such as migration, metastasis, resistance to chemotherapy and immunosuppression. Therefore, a targeting of these cells may be useful for both imaging and therapy. In this respect, an interesting target is the fibroblast activation protein (FAP) which is expressed in activated fibroblasts, but not in quiescent fibroblasts, giving the opportunity to use this membrane-anchored enzyme as a target for radionuclide-based approaches for diagnosis and treatment of tumors and for the diagnosis of non-malignant disease associated with a remodelling of the extracellular matrix. | ||
| 650 | 4 | |a Cancer-associated fibroblast | |
| 650 | 4 | |a Fibroblast activation protein | |
| 650 | 4 | |a Imaging | |
| 650 | 4 | |a Inhibitors | |
| 650 | 4 | |a Tumor stroma | |
| 700 | 1 | |a Loktev, Anastasia |e VerfasserIn |0 (DE-588)1160315728 |0 (DE-627)1023462869 |0 (DE-576)505840170 |4 aut | |
| 700 | 1 | |a Giesel, Frederik L. |d 1970- |e VerfasserIn |0 (DE-588)129031240 |0 (DE-627)387883878 |0 (DE-576)297457071 |4 aut | |
| 700 | 1 | |a Kratochwil, Clemens |d 1978- |e VerfasserIn |0 (DE-588)134026276 |0 (DE-627)559871686 |0 (DE-576)300262787 |4 aut | |
| 700 | 1 | |a Altmann, Annette |e VerfasserIn |0 (DE-588)1032267984 |0 (DE-627)738189111 |0 (DE-576)379930099 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t EJNMMI radiopharmacy and chemistry |d [Cham, Switzerland] : Springer International Publishing, 2016 |g 4(2019), Artikel-ID 16, Seite 1-15 |h Online-Ressource |w (DE-627)844386367 |w (DE-600)2843088-8 |w (DE-576)453511163 |x 2365-421X |7 nnas |a Targeting of activated fibroblasts for imaging and therapy |
| 773 | 1 | 8 | |g volume:4 |g year:2019 |g elocationid:16 |g pages:1-15 |g extent:15 |a Targeting of activated fibroblasts for imaging and therapy |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s41181-019-0069-0 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201207 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 6 |y j | ||
| 998 | |g 1032267984 |a Altmann, Annette |m 1032267984:Altmann, Annette |d 910000 |d 911400 |e 910000PA1032267984 |e 911400PA1032267984 |k 0/910000/ |k 1/910000/911400/ |p 5 | ||
| 998 | |g 134026276 |a Kratochwil, Clemens |m 134026276:Kratochwil, Clemens |d 910000 |d 911400 |e 910000PK134026276 |e 911400PK134026276 |k 0/910000/ |k 1/910000/911400/ |p 4 | ||
| 998 | |g 129031240 |a Giesel, Frederik L. |m 129031240:Giesel, Frederik L. |d 910000 |d 911400 |e 910000PG129031240 |e 911400PG129031240 |k 0/910000/ |k 1/910000/911400/ |p 3 | ||
| 998 | |g 1160315728 |a Loktev, Anastasia |m 1160315728:Loktev, Anastasia |p 2 | ||
| 998 | |g 107520318X |a Lindner, Thomas |m 107520318X:Lindner, Thomas |d 910000 |d 911400 |e 910000PL107520318X |e 911400PL107520318X |k 0/910000/ |k 1/910000/911400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1742221351 |e 3818632650 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","given":"Thomas","display":"Lindner, Thomas","family":"Lindner"},{"role":"aut","family":"Loktev","given":"Anastasia","display":"Loktev, Anastasia"},{"family":"Giesel","given":"Frederik L.","display":"Giesel, Frederik L.","role":"aut"},{"role":"aut","family":"Kratochwil","display":"Kratochwil, Clemens","given":"Clemens"},{"display":"Altmann, Annette","given":"Annette","family":"Altmann","role":"aut"},{"display":"Haberkorn, Uwe","given":"Uwe","family":"Haberkorn","role":"aut"}],"name":{"displayForm":["Thomas Lindner, Anastasia Loktev, Frederik Giesel, Clemens Kratochwil, Annette Altmann and Uwe Haberkorn"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"25 July 2019"}],"recId":"1742221351","title":[{"title":"Targeting of activated fibroblasts for imaging and therapy","title_sort":"Targeting of activated fibroblasts for imaging and therapy"}],"language":["eng"],"physDesc":[{"extent":"15 S."}],"id":{"doi":["10.1186/s41181-019-0069-0"],"eki":["1742221351"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 03.12.2020"],"relHost":[{"title":[{"title":"EJNMMI radiopharmacy and chemistry","title_sort":"EJNMMI radiopharmacy and chemistry"}],"origin":[{"dateIssuedDisp":"[2016]-","publisher":"Springer International Publishing ; SpringerOpen","publisherPlace":"[Cham, Switzerland] ; [Heidelberg]"}],"note":["Gesehen am 29.05.20"],"part":{"text":"4(2019), Artikel-ID 16, Seite 1-15","volume":"4","pages":"1-15","year":"2019","extent":"15"},"id":{"eki":["844386367"],"zdb":["2843088-8"],"issn":["2365-421X"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"disp":"Targeting of activated fibroblasts for imaging and therapyEJNMMI radiopharmacy and chemistry","recId":"844386367","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["2016-"]}]} | ||
| SRT | |a LINDNERTHOTARGETINGO2520 | ||